The Krishna Institute of Medical Sciences Ltd. (KIMS) #IPO Thread #IPOTracker
1/ IPO Details
Date of Offer: 16th June-18th June
Price Band: INR 815-825
Min. Order Qty: 18 Shares
Fresh Issue: INR 200 Cr
Offer for Sale: INR 1944 Cr
2/ Company Details
KIMS is one of the largest healthcare groups in Andhra Pradesh and Telangana in terms of number of patients treated.
KIMS has expanded its hospital network in recent years through acquisition of hospitals in 4 cities 1/3 beds launched in past 4 yrs
3/ Operational Highlights
Operates 9 multi-specialty hospitals under 'KIMS Hospitals' brand
Aggregate bed capacity 3064
Expected to rise to 3800 by FY24
Out-Patient department CAGR -3.96% (FY19-21) due to Covid
This decrease was offset by inpatient CAGR 2.31%
Bed Occupancy 78.6%
4/ Financials
Revenue CAGR 20.4% (FY18-21)
PAT CAGR 105.2%
EBITDA CAGR 114%
Average revenue per occupied bed INR 20609
Utilization of IPO proceeds to pay off debt will help in path towards becoming net debt free
5/ Sector Outlook
Hospital and healthcare service industry is estimated at INR4.3 trillion
Anticipated to grow 17-18% for 4 years
PMJAY expected to increase affordability
Govt introduced INR15000 Cr package for Covid to boost industry
Growth of Medical tourism
6/ Peer Comparison
The company faces stiff competition in the markets
Its primary competitors are Apollo Hospitals, Narayana Hrudayalaya, Shalby, Fortis & Max Healthcare
7/ Promoter & Major Shareholder Details
The promoters of the company, The Bollineni family had 46.81%
General Atlantic Singapore KH Pte. Ltd., largest shareholder of the company (40.91%) is a leading global growth investor providing strategic support to high-growth companies
8/ Strengths
The co has had consistent growth in Revenue with decent profitability
The co has diverse offerings across specialties
KIMS' clinical excellence and affordable healthcare gives it an advantage on peers
KIMS has diversified revenue streams in terms of specialities
9/ Risk Factors
2 hospitals in Hyderabad contributed to 64% of Revenue
Regional concentration exposes co. to economic & political situations
Top 20 Doctors contributed 21.8% of Revenue & Top 25 doctors contributed 36.1%
Covid reduced bed occupancy rate
Capital intensive ops
10/Future Outlook
Plans to expand in adjacent states including Karnataka, Orissa, Tamil Nadu
Exploring Asset lite models of expansion without ownership of assets
Increased clinical team for organ transplantations
Undertaking initiatives to improve daily ARPOB and minimize ALOS
• • •
Missing some Tweet in this thread? You can try to
force a refresh
The company has an installed capacity of 𝟐 𝐜𝐫𝐨𝐫𝐞𝐬 𝐩𝐚𝐢𝐫𝐬 per year and exports footwear to Asian, African and Middle East nations.
There are total 4 manufacturing plants situated at Jaipur and Chomu.
Lehar Footwears largely deals in:
Open-footwear segment (slippers/sandals) and school shoes, with style ranges from casuals wear to formal wear, daily wear to sportswear for every member of family.
#Didyouknow
Ethos Ltd. is India’s largest luxury and premium watch retail player?
The co. has 13% share in the total retail sales in premium and luxury segment and a share of 20% when seen in exclusively luxury segment in FY20. #ethos#ipo
1)It has 50 stores are spread across 17 cities. Ethos has also opened Boutiques in partnership with prominent market leading brands like Rolex.
2)On the co.'s website, visitors can research about the latest watch launches, reviews and choose from over 7,000 premium, bridge to luxury, luxury & high luxury watches across 50 brands and as of Dec 31, 2021, their website had 21,844,216 number of visitor sessions.
Rainbow Children’s Medicare Ltd (RCML) is a leading multi-specialty pediatric, obstetrics & gynecology hospital and had the highest number of hospital beds amongst players in the maternity and pediatric healthcare delivery sector, as of Mar 31, 2021 in India?
1)The co. has 14 hospitals and 3 clinics operating in 6 cities, with a total bed capacity of 1,500 beds, as of Sept 30, 2021.
2)Their core specialties are pediatrics, which includes newborn and pediatric intensive care, pediatric multi-specialty services, pediatric quaternary care (including multi organ transplants); and obstetrics and gynecology, which includes normal and complex obstetric care.
#Didyouknow
Magma Housing Fiannce Ltd (MHF) is a national scale affordable housing financing company with a presence across 16 states?
The company enetered in to General Insurance business through Magma HDI General Insurance Company, a joint venture with HDI
Global SE.
1)The HDI Global SE brand, is a part of Hannover based Talanx group, the 3rd largest German insurance Group operating in around 150 countries in the world.
2)In 2012-13, Magma launched loans for Mortgaged Finance following the acquisition of the mortgage business of GE India.
#Didyouknow
Gujarat Pipavav is a South-West Gujarat based port with an MNC
promoter (APM Terminals–Maersk Group)?
It lies at a strategic international maritime location, which connects India with the Far East on the one side and MiddleEast, Africa, Europe & US on the other. #GPPL
1)GPPL’s revenues has experienced subdued growth of 4.2% CAGR to Rs.734 cr over FY18-21 due to the pandemic, driven by:
• Container cargo revenues degrowing at 3.4% CAGR to Rs.392 cr (17.1% volume CAGR to 748 mn TEU),
2)• Liquid cargo revenues degrowing at 2.4% CAGR to Rs.85 cr (12.3% volume CAGR decline to 0.7 mn MT), and
• Dry bulk cargo revenues growing at 24.2% CAGR to Rs.165 cr (19.9% volume CAGR to 3.1 mn MT).
S Chand & Co is the leading K-12 education content company in terms of revenue from operations in Fiscal 2016, with a strong presence in the CBSE/ICSE affiliated schools and increasing presence in the state board affiliated schools across India?
1)The co. offers 55 consumer brands across knowledge products and services including S. Chand, Vikas, Madhubun, Saraswati, Destination Success and Ignitor.
2)Revenue can be estimated to be around Rs5bn in FY22 aided by price hike of ~5-10%. After having managed a successful turnaround in FY21, NCF implementation remains a key factor to monitor (announcement expected in FY23) as it would set the growth trajectory for next 2-3 years.